L02AB02 medroxyprogesterone
ATC group of level 5 – chemical substance · in plain English: hormone treatment of cancer
This site has the patient leaflet or the SPC of 11 medicines in this group.
- 10 prescription only (POM)
- 1 no longer supplied or not available
Active substance: Medroxyprogesterone – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
- L02A Hormones and related agents 44 medicines
- L02AB Progestogens, endocrine therapy drugs 13 medicines
- L02AB02 medroxyprogesterone 11 medicines
- L02AB Progestogens, endocrine therapy drugs 13 medicines
- L02A Hormones and related agents 44 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Climanor SPC no longer supplied | – |
| Medroxyprogesterone Acetate tablets 10 mg, Provera tablets 10 mg SPC | Prescription only (POM) |
| Provera 10 mg tablets | Prescription only (POM) |
| Provera 10 mg tablets, Medroxyprogesterone Acetate 10 mg tablets | Prescription only (POM) |
| Provera 100 mg tablets | Prescription only (POM) |
| Provera 5 mg tablets | Prescription only (POM) |
| Provera tablets 100 mg SPC | Prescription only (POM) |
| Provera tablets 2.5 mg SPC | Prescription only (POM) |
| Provera tablets 200 mg SPC | Prescription only (POM) |
| Provera tablets 400 mg SPC | Prescription only (POM) |
| Provera tablets 5 mg, Medroxyprogesterone Acetate tablets 5 mg SPC | Prescription only (POM) |
Other groups of the same level
- L02AB01 megestrol 2 medicines
Other names of the ATC group
- Czech: L02AB02 Medroxyprogesteron
- French: L02AB02 médroxyprogestérone
- German: L02AB02 Medroxyprogesteron
- Spanish: L02AB02 MEDROXIPROGESTERONA
- German: L02AB02 Medroxyprogesteron
- Italian: L02AB02 MEDROSSIPROGESTERONE
- Polish: L02AB02 MEDROXYPROGESTERON
- Turkish: L02AB02 medroksiprogesteron
- Portuguese (Brazil): L02AB02 Medroxiprogesterona
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L02AB02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.